| Literature DB >> 30845345 |
Chen Chen1, Yunhua Sheng2, Yue Hu2, Jie Sun2, Wei Li1, Hongmin Feng1, Liming Tang2.
Abstract
The aim of the present study was to develop a method based on gas chromatography-tandem mass spectrometry (GC-MS/MS) to determine and quantify the d-limonene in mouse plasma and tissue samples. This new method was validated for the quantification of d-limonene with the linearity ranges 1.0-1000.0 ng/mL (r2 > 0.9952) for plasma samples and 5.0-5000.0 ng/g (r2 > 0.9940) for tissue samples. The intra- and inter-day assay of precisions in plasma and tissues were <13.4% and the accuracies were within 91.1-105.8%. In the oral/inhalation administration pharmacokinetics and tissue distribution studies, the main pharmacokinetic parameters were the peak concentration = (97.150 ± 34.450)/(4336.415 ± 1142.418) ng/mL, the area under the curve = (162.828± 27.447)/(2085.721 ± 547.787) h ng/mL and the half-life = (3.196 ± 0.825)/(0.989 ± 0.095) h. The tissue distribution of d-limonene in mice after oral/inhalation administration demonstrated a decreasing tendency in different tissues (liver > kidney > heart > lung > spleen).Entities:
Keywords: d-limonene; gas chromatography-tandem mass spectrometry; pharmacokinetics; tissue distribution
Mesh:
Substances:
Year: 2019 PMID: 30845345 DOI: 10.1002/bmc.4530
Source DB: PubMed Journal: Biomed Chromatogr ISSN: 0269-3879 Impact factor: 1.902